- Home
- » Tags
- » Diprenorphine
Top View
- (12) United States Patent (10) Patent No.: US 7,201.920 B2 Kumar Et Al
- Benefits and Risks of Pharmaceutical Opioids
- Naltrexone-Buprenorphine Interactions: Effects on Cocaine Self-Administration Nancy K
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- A Guide to New Opioid Prescribing Rules
- WITH ETORPHINE, and REVERSAL with NALTREXONE Author(S): Rolf-Arne Ølberg, D.V.M., D.V.Sc., Kit M
- How Best Can We Control Pain in Dogs and Cats
- Chemical Immobilization of Wild Ruminants D
- Use of Butorphanol and Diprenorphine to Counter Respiratory Impairment in the Immobilised White Rhinoceros (Ceratotherium Simum)
- Use of a Pure Narcotic Antagonist, E.G. Nalmefene, Naltrexone, Naloxone Or Diprenorphine, in the Treatment of Mast Cell Disease
- Drug Diversion Training
- Diprenorphine Elisa Kit Instructions Product #106119 & 106116 Forensic Use Only
- Novel Opiate Binding Sites Selective for Benzomorphan Drugs
- FOI Summary, Trexonil (Naltrexone Hydrochloride), MIF 900-003
- Buprenorphine: an Alternative Treatment for Opioid Dependence
- Morphine Cross-Reacts with Somatostatin Receptor SSTR2 in the T47D Human Breast Cancer Cell Line and Decreases Cell Growth'
- FDA Advisory Committee on the Most Appropriate Dose Or Doses of Naloxone to Reverse the Effects of Life-Threatening Opioid Overdose in the Community Settings
- 2-[18F]Fluoroethyl)-6-O-Desmethyldiprenorphine ([18F]DPN):Synthesis, Biologic Evaluation, and Comparison with [UC]Dpnin Humans
- Molecular Mechanisms by Which Salvinorin a Binds to and Activates the Kappa-Opioid Receptor
- \Llllllllllllllllllilllllllllllllllllllllllllllllllllllllllllllllllllllllll US005512578A United States Patent [19] [11] Patent Number: 5,512,578 Crain Et Al
- Opioid Receptor Density and G Protein Activation in the Cortex and Thalamus of Monkeys
- Downloaded from Pushshift.Io and the Reddit API18
- Evaluation of Etorphine Reversed by Diprenorphine for the Immobilisation of Free- Ranging Atlantic Walrus ( Odobenus Rosmarus Rosmarus L.)
- (12) Patent Application Publication (10) Pub. No.: US 2003/0004177 A1 Kao Et Al
- Mesh Terms for 2002
- Zim-51 Binding Site
- Pharmaceutical Appendix to the Tariff Schedule 2
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Method of Administering Narcotic Antagonists and Analgesics and Novel Dosage Forms Containing Same Anwar A
- Pdf of Article
- Brain Opioid Receptor Binding in Early Abstinence from Opioid
- Some Controversies Related to Questionable Clinical Uses Of
- Solutions for Forensic Drug Detection
- Opioid Antagonist Diprenorphine Microinjected Into Parabrachial Nucleus Selectively Inhibits Vasopressin Response to Hypovolemic Stimuli in the Rat
- Salvinorin A: Fragment Synthesis and Modeling Studies
- UCLA Previously Published Works
- Drugs of Abuse (2017 Edition)
- Comprehensive Molecular Pharmacology Screening Reveals Potential New Receptor Interactions for Clinically Relevant Opioids
- Neogen Forensic Catalog
- Agonist and Antagonist Properties of Buprenorphine, a New Antinociceptive Agent
- Optimal Duration of PET Studies with 18F-Fluoroethyl-Diprenorphine